0HWG.L | The Chemours Company Annual & Quarterly Balance

Annual Balance Sheets

(In USD)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	8.25 Billion	7.64 Billion	7.55 Billion	7.08 Billion	7.25 Billion	7.36 Billion
Total Current Assets	3.83 Billion	3.21 Billion	3.34 Billion	2.63 Billion	2.77 Billion	3.29 Billion
Cash And Short Term Investments	1.2 Billion	1.1 Billion	1.45 Billion	1.1 Billion	943 Million	1.2 Billion
Cash and Cash Equivalents	1.2 Billion	1.1 Billion	1.45 Billion	1.1 Billion	943 Million	1.2 Billion
Short Term Investments	-	-	-	-	-	-
Net Receivables	509 Million	626 Million	720 Million	511 Million	674 Million	861 Million
Inventory	1.35 Billion	1.4 Billion	1.09 Billion	939 Million	1.07 Billion	1.14 Billion
Other Current Assets	771 Million	82 Million	75 Million	78 Million	81 Million	84 Million
Total Non-Current Assets	4.41 Billion	4.42 Billion	4.2 Billion	4.44 Billion	4.48 Billion	4.06 Billion
Net PPE	3.47 Billion	3.41 Billion	3.38 Billion	3.71 Billion	3.85 Billion	3.29 Billion
Good Will And Intangible Assets	105 Million	115 Million	108 Million	167 Million	174 Million	181 Million
Good Will	102 Million	102 Million	102 Million	153 Million	153 Million	153 Million
Intangible Assets	3 Million	13 Million	6 Million	14 Million	21 Million	28 Million
Long-Term Investments	158 Million	377 Million	269 Million	167 Million	162 Million	160 Million
Tax Assets	303 Million	152 Million	171 Million	95 Million	40 Million	46 Million
Other Non Current Assets	374 Million	371 Million	276 Million	310 Million	252 Million	391 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	7.51 Billion	6.53 Billion	6.46 Billion	6.26 Billion	6.56 Billion	6.34 Billion
Total Current Liabilities	2.48 Billion	1.89 Billion	1.85 Billion	1.44 Billion	1.54 Billion	1.7 Billion
Account Payables	1.15 Billion	1.21 Billion	1.14 Billion	820 Million	901 Million	1.11 Billion
Tax Payables	28 Million	19 Million	43 Million	64 Million	65 Million	87 Million
Short Term Debt	39 Million	92 Million	84 Million	78 Million	200 Million	13 Million
Deferred Revenue	28 Million	19 Million	3 Million	7 Million	7 Million	6 Million
Other Current Liabilities	1.26 Billion	570 Million	630 Million	537 Million	433 Million	579 Million
Total Non Current Liabilities	5.02 Billion	4.64 Billion	4.61 Billion	4.82 Billion	5.02 Billion	4.63 Billion
Long-Term Debt	4.19 Billion	3.54 Billion	3.66 Billion	3.93 Billion	3.97 Billion	3.95 Billion
Deferred Revenue Non Current	252 Million	247 Million	2 Million	5 Million	8 Million	7 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	537 Million	793 Million	895 Million	846 Million	924 Million	450 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	739 Million	1.1 Billion	1.08 Billion	815 Million	695 Million	1.02 Billion
Stock Holders Equity	737 Million	1.1 Billion	1.08 Billion	813 Million	689 Million	1.01 Billion
Common Stock	2 Million	2 Million	2 Million	2 Million	2 Million	2 Million
Retained Earnings	1.78 Billion	2.17 Billion	1.74 Billion	1.3 Billion	1.24 Billion	1.46 Billion
Accumulated other comprehensive income	-274 Million	-343 Million	-364 Million	-310 Million	-349 Million	-564 Million
Common Stock Equity	737 Million	1.1 Billion	1.08 Billion	813 Million	689 Million	1.01 Billion
Capital Lease Obligation	319 Million	247 Million	239 Million	261 Million	299 Million	2 Million
Total Investments	158 Million	377 Million	269 Million	167 Million	162 Million	160 Million
Total Debt	4.23 Billion	3.88 Billion	3.98 Billion	4.27 Billion	4.47 Billion	3.97 Billion
Net Debt	3.02 Billion	2.77 Billion	2.53 Billion	3.17 Billion	3.52 Billion	2.77 Billion

Breakdown	2024 Q3	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3
Total Assets	7.46 Billion	7.24 Billion	7.97 Billion	8.25 Billion	8.25 Billion	7.94 Billion
Total Current Assets	3.08 Billion	2.93 Billion	3.59 Billion	3.83 Billion	3.83 Billion	3.68 Billion
Cash And Short Term Investments	616 Million	604 Million	1.35 Billion	1.8 Billion	1.8 Billion	1.44 Billion
Cash and Cash Equivalents	616 Million	604 Million	1.35 Billion	1.8 Billion	1.8 Billion	1.44 Billion
Short Term Investments	-	-	-	-	-	-
Net Receivables	951 Million	788 Million	792 Million	610 Million	610 Million	846 Million
Inventory	1.43 Billion	1.36 Billion	1.39 Billion	1.35 Billion	1.35 Billion	1.31 Billion
Other Current Assets	75 Million	177 Million	61 Million	66 Million	66 Million	76 Million
Total Non-Current Assets	4.38 Billion	4.31 Billion	4.38 Billion	4.41 Billion	4.41 Billion	4.26 Billion
Net PPE	3.42 Billion	3.4 Billion	3.46 Billion	3.47 Billion	3.47 Billion	3.37 Billion
Good Will And Intangible Assets	49 Million	105 Million	105 Million	105 Million	105 Million	107 Million
Good Will	46 Million	102 Million	102 Million	102 Million	102 Million	102 Million
Intangible Assets	3 Million	3 Million	3 Million	3 Million	3 Million	5 Million
Long-Term Investments	240 Million	169 Million	165 Million	158 Million	158 Million	192 Million
Tax Assets	333 Million	303 Million	301 Million	303 Million	303 Million	277 Million
Other Non Current Assets	334 Million	327 Million	349 Million	374 Million	374 Million	312 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	6.8 Billion	6.52 Billion	7.22 Billion	7.51 Billion	7.51 Billion	7.19 Billion
Total Current Liabilities	1.77 Billion	1.55 Billion	2.23 Billion	2.48 Billion	2.48 Billion	2.19 Billion
Account Payables	1.03 Billion	938 Million	939 Million	1.13 Billion	1.13 Billion	878 Million
Tax Payables	-	13 Million	26 Million	28 Million	28 Million	67 Million
Short Term Debt	106 Million	30 Million	94 Million	106 Million	106 Million	78 Million
Deferred Revenue	12 Million	16 Million	14 Million	28 Million	28 Million	5 Million
Other Current Liabilities	622 Million	573 Million	1.18 Billion	1.21 Billion	1.21 Billion	1.23 Billion
Total Non Current Liabilities	5.02 Billion	4.96 Billion	4.99 Billion	5.02 Billion	5.02 Billion	4.99 Billion
Long-Term Debt	3.98 Billion	4.14 Billion	3.96 Billion	3.94 Billion	3.94 Billion	3.94 Billion
Deferred Revenue Non Current	196 Million	195 Million	198 Million	252 Million	252 Million	207 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	802 Million	585 Million	783 Million	789 Million	789 Million	791 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	659 Million	725 Million	754 Million	739 Million	739 Million	757 Million
Stock Holders Equity	657 Million	723 Million	752 Million	737 Million	737 Million	755 Million
Common Stock	2 Million	2 Million	2 Million	2 Million	2 Million	2 Million
Retained Earnings	1.76 Billion	1.82 Billion	1.79 Billion	1.78 Billion	1.78 Billion	1.84 Billion
Accumulated other comprehensive income	-353 Million	-347 Million	-274 Million	-274 Million	-274 Million	-315 Million
Common Stock Equity	657 Million	723 Million	752 Million	737 Million	737 Million	755 Million
Capital Lease Obligation	-	297 Million	198 Million	252 Million	252 Million	207 Million
Total Investments	240 Million	169 Million	165 Million	158 Million	158 Million	192 Million
Total Debt	4.09 Billion	4.17 Billion	4.26 Billion	4.29 Billion	4.29 Billion	4.22 Billion
Net Debt	3.47 Billion	3.57 Billion	2.9 Billion	2.49 Billion	2.49 Billion	2.78 Billion

Balance Sheet Charts

PT Semen Baturaja (Persero) Tbk

SMBR

Full Analysis

Annual Balance Sheets
Salcef Group S.p.A.

SCF

Full Analysis

Annual Balance Sheets
India Glycols Limited

INDIAGLYCO

Full Analysis

Annual Balance Sheets
Cognizant Technology Solutions Corporation

COZ

Full Analysis

Annual Balance Sheets
Tube Investments of India Limited

TIINDIA

Full Analysis

Annual Balance Sheets
ZAOH Company, Ltd.

9986

Full Analysis

Annual Balance Sheets

Global Stocks Search

The Chemours Company (0HWG.L)

Annual Balance Sheets

Balance Sheet Charts

PT Semen Baturaja (Persero) Tbk

Salcef Group S.p.A.

India Glycols Limited

Cognizant Technology Solutions Corporation

Tube Investments of India Limited

ZAOH Company, Ltd.